Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03121287 · ClinicalTrials.gov registry record
Early Imaging Biomarkers in NSCLC
A clinical trial of Thoracic Cancer, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT03121287: Completed study of Thoracic Cancer, sponsored by University of Michigan Rogel Cancer Center.
NCT03121287 is a study of Thoracic Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 23 participants, below the 347-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03121287, a study of Thoracic Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate if cardiac MRI, blood biomarkers, and lung CT scans can detect early changes to the associated with radiation therapy in patients receiving radiation treatment for thoracic cancer.
Primary Outcome
To characterize longitudinal changes in lung function using a voxel-wise image analysis technique of whole-lung CT scans in patients undergoing intrathoracic radiation therapy.
Conditions Studied
Interventions
- OTHER Specimen Collection
- OTHER Imaging
- OTHER Imaging Biomarkers
- OTHER Pulmonary
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-09-23 |
| Est. Completion | 2019-01 |
What the finished NCT03121287 record still lists
NCT03121287 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 347-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Thoracic Cancer appearing as the primary indexed condition, and to 4 interventions - of which Specimen Collection is the first listed.
NCT03121287 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03121287 about?
NCT03121287 is a clinical study titled "Early Imaging Biomarkers in NSCLC". The purpose of this study is to investigate if cardiac MRI, blood biomarkers, and lung CT scans can detect early changes to the associated with radiation therapy in patients receiving radiation treatment for thoracic cancer.
What is the current status of trial NCT03121287?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2015-09-23. Estimated completion is 2019-01.
What conditions does trial NCT03121287 study?
This clinical trial studies the following conditions: Thoracic Cancer.
What interventions are being tested in trial NCT03121287?
The interventions under investigation include: Specimen Collection (OTHER), Imaging (OTHER), Imaging Biomarkers (OTHER), Pulmonary (OTHER).
Who is sponsoring clinical trial NCT03121287?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03121287 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03121287's enrollment target sits among peer trials
23 13th of 15 higher than 3 of 15 other Thoracic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thoracic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Erector Spinae Block for Thoracic Surgery
RECRUITING · Phase 4
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RECRUITING
-
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RECRUITING · Phase 1
-
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI